Cephalothin, a First-Generation Cephem Antibiotic, Works as a Potent Inducer of Parthanatos.

IF 1.7 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Ryo Ito, Takaya Komatsu, Takuya Noguchi, Tomohiro Kagi, Yusuke Hirata, Atsushi Matsuzawa
{"title":"Cephalothin, a First-Generation Cephem Antibiotic, Works as a Potent Inducer of Parthanatos.","authors":"Ryo Ito, Takaya Komatsu, Takuya Noguchi, Tomohiro Kagi, Yusuke Hirata, Atsushi Matsuzawa","doi":"10.1248/bpb.b25-00401","DOIUrl":null,"url":null,"abstract":"<p><p>Parthanatos is a noncanonical form of regulated cell death mediated by the overactivation of poly(ADP-ribose) polymerase-1, yet its regulatory mechanisms are not fully understood. To fully elucidate its regulatory mechanisms, it is necessary to establish useful research tools to investigate parthanatos. We have previously identified the human fibrosarcoma HT1080 cells as highly sensitive cells to parthanatos, and cefotaxime, a 3rd-generation cephem antibiotic, as the parthanatos inducer. In this study, we comprehensively characterized the ability of various cephem antibiotics, including cephalothin (also called cefalotin) (CET), cefoxitin, ceftriaxone, cefoperazone, ceftezole, and cefalexin, to induce parthanatos. Among them, CET exhibited the lowest LD<sub>50</sub>. Therefore, our results show that CET works as the more potent and useful parthanatos inducer.</p>","PeriodicalId":8955,"journal":{"name":"Biological & pharmaceutical bulletin","volume":"48 9","pages":"1351-1357"},"PeriodicalIF":1.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological & pharmaceutical bulletin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1248/bpb.b25-00401","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Parthanatos is a noncanonical form of regulated cell death mediated by the overactivation of poly(ADP-ribose) polymerase-1, yet its regulatory mechanisms are not fully understood. To fully elucidate its regulatory mechanisms, it is necessary to establish useful research tools to investigate parthanatos. We have previously identified the human fibrosarcoma HT1080 cells as highly sensitive cells to parthanatos, and cefotaxime, a 3rd-generation cephem antibiotic, as the parthanatos inducer. In this study, we comprehensively characterized the ability of various cephem antibiotics, including cephalothin (also called cefalotin) (CET), cefoxitin, ceftriaxone, cefoperazone, ceftezole, and cefalexin, to induce parthanatos. Among them, CET exhibited the lowest LD50. Therefore, our results show that CET works as the more potent and useful parthanatos inducer.

头孢菌素是第一代头孢菌素抗生素,是一种有效的Parthanatos诱导剂。
Parthanatos是由poly(adp -核糖)聚合酶-1过度激活介导的一种非规范形式的细胞死亡,但其调控机制尚不完全清楚。为了充分阐明其调控机制,有必要建立有用的研究工具来研究parthanatos。我们之前已经发现人类纤维肉瘤HT1080细胞是对parthanatos高度敏感的细胞,而第三代头孢噻肟抗生素是parthanatos诱导剂。在本研究中,我们全面表征了各种头孢类抗生素,包括头孢素(也称为头孢肽)(CET)、头孢西丁、头孢曲松、头孢哌酮、头孢唑和头孢alexin诱导parthanatos的能力。其中,CET的LD50最低。因此,我们的研究结果表明,CET是一种更有效和有用的对苯二甲酸盐诱导剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
5.00%
发文量
247
审稿时长
2 months
期刊介绍: Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信